NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
01 4NanoAlvand
02 3Apotex Inc
03 1Incyte Biosciences Distribution
04 11Incyte Corporation
05 54Novartis Pharmaceuticals Corporation
06 3Novartis South Africa (Pty) Ltd
07 2ORIFARM GROUP AS
01 1CREAM
02 1CREAM;TOPICAL
03 5Cream
04 3Oral Solution
05 1Syrup
06 3TAB
07 4TABLET
08 3TABLET; ORAL
09 5TABLET;ORAL
10 30Tablet
11 22Blank
01 6Allowed
02 6Approved
03 6Authorized
04 5Marketed
05 2Not Marketed
06 3Originator
07 15Prescription
08 6RX
09 29Blank
01 5JAKAFI
02 4JAKAVI
03 4Jackavi
04 44Jakavi
05 1Jakavi 15 mg
06 1Jakavi 20 mg
07 1Jakavi 5 mg
08 2OPZELURA
09 4Opzelura
10 1Opzelura g
11 4Relata
12 3Ruxolitinib
13 4Strong
01 22Australia
02 5Canada
03 5Denmark
04 5Estonia
05 4Iran
06 7Norway
07 3South Africa
08 6Spain
09 6Sweden
10 6Switzerland
11 9USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Relata
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Relata
Dosage Form : Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Relata
Dosage Form : Tablet
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Relata
Dosage Form : Tablet
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : USA
Brand Name : Ruxolitinib
Dosage Form : TABLET; ORAL
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 219660
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : Ruxolitinib
Dosage Form : TABLET; ORAL
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number : 219660
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : Ruxolitinib
Dosage Form : TABLET; ORAL
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number : 219660
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 20MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OPZELURA
Dosage Form : CREAM;TOPICAL
Dosage Strength : EQ 1.5% BASE
Packaging :
Approval Date : 2021-09-21
Application Number : 215309
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Opzelura g
Dosage Form : Cream
Dosage Strength : 15mg
Packaging :
Approval Date : 30/01/2025
Application Number : 69443
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 5mg
Packaging :
Approval Date : 27/12/2012
Application Number : 62126
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 15mg
Packaging :
Approval Date : 27/12/2012
Application Number : 62126
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 20mg
Packaging :
Approval Date : 27/12/2012
Application Number : 62126
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 10mg
Packaging :
Approval Date : 27/12/2012
Application Number : 62126
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Oral Solution
Dosage Strength : 5mg/ml
Packaging :
Approval Date : 27/03/2025
Application Number : 69722
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 10mg
Packaging :
Approval Date : 03/10/2014
Application Number : 20140311000017
Regulatory Info : Approved
Registration Country : Sweden
